References
- A Casadevall, Perfect, JR, eds. Cryptococcus neoformans. Washington DC: ASM Press, 1998: 1–27.
- JW Rippon, ed. Cryptococcosis. In:. Medical Mycology, 3rd edn. Philadelphia: WB Saunders, 1988: 582–611.
- Chen SC, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?. J Infect Dis 1997; 175: 414–420
- Chen SC, Wright LC, Santangelo RT, et al. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun 1997; 65: 405–411
- Cox GM, McDade HC, Chen SC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39: 166–175
- Vidotto V, Sinnicco A, Fraia DD, Cardaropoli S, Aoki S, Ito-Kuwa S. Phospholipase activity in Cryptococcus neoformans. Mycopathologia 1996; 136: 119–123
- Noverr MC, Cox GM, Perfect JR, Huffnagle GB. Role of phospholipase B 1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 2003; 71: 1538–1547
- Santangelo R, Zoellner H, Sorrell T, et al. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 2004; 72: 2229–2239
- Chen SC, Wright LC, Golding JC, Sorrell TC. Purification and characterization of secretory phospholipase B, lysophospholipase, and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neformans. Biochem J 2000; 347: 431–439
- Himmelreich U, Dzendrowskyj TE, Allen C, et al. Cryptococcomas distinguished from gliomas by magnetic resonance spectroscopy: an experimental rat and cell culture study. Radiology 2001; 220: 122–128
- Wang B, Hak LJ, Relling MV, et al. ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia. J Immunol Methods 2000; 239: 75–83
- Kaufman, L, Blumer, S. Cryptococcosis: the awakening giant. In: Proceedings of the Fourth International Conference on the Mycoses. Pan American Health Organization Scientific Publication no. 356, 1977: 176–182.
- Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794–799
- Clancy, CJ, Ghannoum, MA, Nguygen, MH. Abstracts of the 36th Annual Meeting of Infectious Diseases Society of America, 1998: Abstract no. 317.
- Samaranayake LP, Raeside JM, MacFarlane TW. Factors affecting the phospholipase activity of Candida species in vitro. Sabouraudia 1984; 22: 201–207
- Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7–14
- Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122–143
- Titball RW. Bacterial phospholipases C. Clin Microbiol Rev 1993; 57: 347–366
- TG Parslow, Stites, DP, Terr, AI, Imboden, JB, eds. Immunoglobulins and Immunoglobulin Genes. In. Medical Immunology, 10th edn, New York: McGraw-Hill Medical, 2001: 101.
- Ganendren R, Widmer F, Singhal V, Wilson C, Sorrell T, Wright L. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans. Antimicrob Agents Chemother 2004; 48: 1561–1569